Related Experiment Video
Updated: Mar 6, 2026

09:49
Author Spotlight: Insights into the Use of Apple-Derived Cellulose Scaffolds for Bone Tissue Engineering
Published on: February 23, 2024
2.8K
Applied Induced Pluripotent Stem Cells in Combination With Biomaterials in Bone Tissue Engineering
1Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Journal of Cellular Biochemistry
|March 20, 2017
Summary
Induced pluripotent stem cells (iPSCs) show promise for bone tissue engineering. This review explores studies combining iPSCs with natural and synthetic biomaterials for orthopedic lesion treatments.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Stem Cell Biology
Background:
- Orthopedic lesions and fractures are increasing globally, necessitating advanced treatments.
- Current orthopedic treatments have limitations, driving research into tissue engineering and regenerative medicine.
- Induced pluripotent stem cells (iPSCs) offer high proliferation and differentiation potential for regenerative applications.
Purpose of the Study:
- To review studies on bone tissue engineering using induced pluripotent stem cells (iPSCs).
- To examine the combination of iPSCs with natural and synthetic biomaterials for bone regeneration.
Main Methods:
- Literature review of studies in bone tissue engineering.
- Focus on research utilizing induced pluripotent stem cells (iPSCs).
- Analysis of studies employing natural and synthetic biomaterials as scaffolds.
Main Results:
- Induced pluripotent stem cells (iPSCs) are a promising cell source for bone tissue engineering.
- Biomaterials, both natural and synthetic, are crucial components of scaffolds for iPSC delivery.
- Combinations of iPSCs and biomaterials show potential for regenerating bone defects.
Conclusions:
- The combination of iPSCs and biomaterials represents a significant advancement in bone tissue engineering.
- Further research is warranted to optimize iPSC-based therapies for orthopedic applications.
- Tissue engineering strategies hold promise for addressing the limitations of current orthopedic treatments.
Related Concept Videos
Induced Pluripotent Stem Cells
28.2K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.2K
Induced Pluripotent Stem Cells
5.7K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.7K

